statistiche ricercatore

Continente	#
NA - Nord America	520
AS - Asia	396
EU - Europa	312
SA - Sud America	60
Continente sconosciuto - Info sul continente non disponibili	29
AF - Africa	22
OC - Oceania	2
Totale	1.341

Nazione	#
US - Stati Uniti d'America	509
CN - Cina	187
IE - Irlanda	98
SG - Singapore	91
BR - Brasile	45
DE - Germania	42
IT - Italia	39
RU - Federazione Russa	37
FI - Finlandia	35
VN - Vietnam	35
HK - Hong Kong	31
FR - Francia	16
IN - India	16
ZA - Sudafrica	15
GB - Regno Unito	9
JP - Giappone	8
BD - Bangladesh	7
ES - Italia	7
PL - Polonia	6
CA - Canada	5
SE - Svezia	5
AR - Argentina	4
TR - Turchia	4
CL - Cile	3
CO - Colombia	3
IQ - Iraq	3
LT - Lituania	3
MA - Marocco	3
AL - Albania	2
AU - Australia	2
BE - Belgio	2
BO - Bolivia	2
CZ - Repubblica Ceca	2
DK - Danimarca	2
DO - Repubblica Dominicana	2
EG - Egitto	2
MX - Messico	2
NL - Olanda	2
PK - Pakistan	2
UY - Uruguay	2
AT - Austria	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BN - Brunei Darussalam	1
ET - Etiopia	1
GE - Georgia	1
ID - Indonesia	1
IL - Israele	1
IR - Iran	1
JO - Giordania	1
KG - Kirghizistan	1
LB - Libano	1
LV - Lettonia	1
PH - Filippine	1
PT - Portogallo	1
QA - Qatar	1
SA - Arabia Saudita	1
TN - Tunisia	1
UA - Ucraina	1
VC - Saint Vincent e Grenadine	1
VE - Venezuela	1
VG - Isole Vergini Britanniche	1
Totale	1.312

Nome	#
A patient with AL amyloidosis with negative free light chain results	129
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays	128
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis	120
Self-assembled monolayers of Prussian blue nanoparticles with photothermal effect	112
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells	109
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis	109
Urinary albumin to creatinine ratio in diagnosis and risk stratification of renal AL amyloidosis	105
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response	103
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcome	95
A case of monoclonal gammopathy of renal significance	93
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: Prospective study in 206 patients	84
Clonal biomarkers for diagnosis and response to treatment assessment in light chain amyloidosis: The role of the laboratory	82
Unexplained Hyperthyrotropinemia: A Biochemical and Clinical Challenge	72
Totale	1.341

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	39	0	0	0	0	0	1	0	6	1	0	4	27
2022/2023	217	22	20	5	9	13	18	3	7	110	1	5	4
2023/2024	101	13	23	7	6	9	13	2	6	0	5	8	9
2024/2025	203	9	17	2	4	2	21	14	3	49	9	25	48
2025/2026	577	48	35	49	108	72	23	70	33	60	33	11	35
2026/2027	18	9	9	0	0	0	0	0	0	0	0	0	0
Totale													1.341